Incidence of brain metastases on follow-up 18F-FDG PET/CT scans of non-small cell lung cancer patients: Should we include the brain?

Emily S Nia, Linda L. Garland, Naghmehossadat Eshghi, Benjamin B. Nia, Ryan J. Avery, Phillip H. Kuo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The brain is the most common site of distant metastasis from lung cancer. Thus, MRI of the brain at initial staging is routinely performed, but if this examination is negative a follow-up examination is often not performed. This study evaluates the incidence of asymptomatic brain metastases in non-small cell lung cancer patients detected on follow-up 18F-FDG PET/CT scans. Methods: In this Institutional Review Board-approved retrospective review, all vertex to thigh 18F-FDG PET/CT scans in patients with all subtypes of lung cancer from August 2014 to August 2016 were reviewed. A total of 1,175 18F-FDG PET/CT examinations in 363 patients were reviewed. Exclusion criteria included brain metastases on initial staging, histologic subtype of small-cell lung cancer, and no follow-up 18F-FDG PET/CT examinations. After our exclusion criteria were applied, a total of 809 follow-up 18F-FDG PET/CT scans in 227 patients were included in the final analysis. The original report of each 18F-FDG PET/CT study was reviewed for the finding of brain metastasis. The finding of a new brain metastasis prompted a brain MRI, which was reviewed to determine the accuracy of the 18F-FDG PET/CT. Results: Five of 227 patients with 809 follow-up 18F-FDG PET/CT scans reviewed were found to have incidental brain metastases. The mean age of the patients with incidental brain metastasis was 68 y (range, 60-77 y). The mean time from initial diagnosis to time of detection of incidental brain metastasis was 36 mo (range, 15-66 mo). When MRI was used as the gold standard, our false-positive rate was zero. Conclusion: By including the entire head during follow-up 18F-FDG PET/CT scans of patients with non-small cell lung cancer, brain metastases can be detected earlier while still asymptomatic. But, given the additional scan time, radiation, and low incidence of new brain metastases in asymptomatic patients, the cost-to-benefit ratio should be weighed by each institution.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalJournal of Nuclear Medicine Technology
Volume45
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Incidence
Brain
Lung Neoplasms
Positron Emission Tomography Computed Tomography
Research Ethics Committees
Small Cell Lung Carcinoma
Thigh
Brain Neoplasms
Cost-Benefit Analysis
Cohort Studies
Head
Radiation

Keywords

  • Brain MRI
  • Brain metastasis
  • F-FDG PET/CT
  • Incidental
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

Incidence of brain metastases on follow-up 18F-FDG PET/CT scans of non-small cell lung cancer patients : Should we include the brain? / Nia, Emily S; Garland, Linda L.; Eshghi, Naghmehossadat; Nia, Benjamin B.; Avery, Ryan J.; Kuo, Phillip H.

In: Journal of Nuclear Medicine Technology, Vol. 45, No. 3, 01.09.2017, p. 193-197.

Research output: Contribution to journalArticle

Nia, Emily S ; Garland, Linda L. ; Eshghi, Naghmehossadat ; Nia, Benjamin B. ; Avery, Ryan J. ; Kuo, Phillip H. / Incidence of brain metastases on follow-up 18F-FDG PET/CT scans of non-small cell lung cancer patients : Should we include the brain?. In: Journal of Nuclear Medicine Technology. 2017 ; Vol. 45, No. 3. pp. 193-197.
@article{097c7727696549c68b0374d27cfcbe10,
title = "Incidence of brain metastases on follow-up 18F-FDG PET/CT scans of non-small cell lung cancer patients: Should we include the brain?",
abstract = "The brain is the most common site of distant metastasis from lung cancer. Thus, MRI of the brain at initial staging is routinely performed, but if this examination is negative a follow-up examination is often not performed. This study evaluates the incidence of asymptomatic brain metastases in non-small cell lung cancer patients detected on follow-up 18F-FDG PET/CT scans. Methods: In this Institutional Review Board-approved retrospective review, all vertex to thigh 18F-FDG PET/CT scans in patients with all subtypes of lung cancer from August 2014 to August 2016 were reviewed. A total of 1,175 18F-FDG PET/CT examinations in 363 patients were reviewed. Exclusion criteria included brain metastases on initial staging, histologic subtype of small-cell lung cancer, and no follow-up 18F-FDG PET/CT examinations. After our exclusion criteria were applied, a total of 809 follow-up 18F-FDG PET/CT scans in 227 patients were included in the final analysis. The original report of each 18F-FDG PET/CT study was reviewed for the finding of brain metastasis. The finding of a new brain metastasis prompted a brain MRI, which was reviewed to determine the accuracy of the 18F-FDG PET/CT. Results: Five of 227 patients with 809 follow-up 18F-FDG PET/CT scans reviewed were found to have incidental brain metastases. The mean age of the patients with incidental brain metastasis was 68 y (range, 60-77 y). The mean time from initial diagnosis to time of detection of incidental brain metastasis was 36 mo (range, 15-66 mo). When MRI was used as the gold standard, our false-positive rate was zero. Conclusion: By including the entire head during follow-up 18F-FDG PET/CT scans of patients with non-small cell lung cancer, brain metastases can be detected earlier while still asymptomatic. But, given the additional scan time, radiation, and low incidence of new brain metastases in asymptomatic patients, the cost-to-benefit ratio should be weighed by each institution.",
keywords = "Brain MRI, Brain metastasis, F-FDG PET/CT, Incidental, Non-small cell lung cancer",
author = "Nia, {Emily S} and Garland, {Linda L.} and Naghmehossadat Eshghi and Nia, {Benjamin B.} and Avery, {Ryan J.} and Kuo, {Phillip H.}",
year = "2017",
month = "9",
day = "1",
doi = "10.2967/jnmt.117.194571",
language = "English (US)",
volume = "45",
pages = "193--197",
journal = "Journal of Nuclear Medicine Technology",
issn = "0091-4916",
publisher = "Society of Nuclear Medicine Inc.",
number = "3",

}

TY - JOUR

T1 - Incidence of brain metastases on follow-up 18F-FDG PET/CT scans of non-small cell lung cancer patients

T2 - Should we include the brain?

AU - Nia, Emily S

AU - Garland, Linda L.

AU - Eshghi, Naghmehossadat

AU - Nia, Benjamin B.

AU - Avery, Ryan J.

AU - Kuo, Phillip H.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The brain is the most common site of distant metastasis from lung cancer. Thus, MRI of the brain at initial staging is routinely performed, but if this examination is negative a follow-up examination is often not performed. This study evaluates the incidence of asymptomatic brain metastases in non-small cell lung cancer patients detected on follow-up 18F-FDG PET/CT scans. Methods: In this Institutional Review Board-approved retrospective review, all vertex to thigh 18F-FDG PET/CT scans in patients with all subtypes of lung cancer from August 2014 to August 2016 were reviewed. A total of 1,175 18F-FDG PET/CT examinations in 363 patients were reviewed. Exclusion criteria included brain metastases on initial staging, histologic subtype of small-cell lung cancer, and no follow-up 18F-FDG PET/CT examinations. After our exclusion criteria were applied, a total of 809 follow-up 18F-FDG PET/CT scans in 227 patients were included in the final analysis. The original report of each 18F-FDG PET/CT study was reviewed for the finding of brain metastasis. The finding of a new brain metastasis prompted a brain MRI, which was reviewed to determine the accuracy of the 18F-FDG PET/CT. Results: Five of 227 patients with 809 follow-up 18F-FDG PET/CT scans reviewed were found to have incidental brain metastases. The mean age of the patients with incidental brain metastasis was 68 y (range, 60-77 y). The mean time from initial diagnosis to time of detection of incidental brain metastasis was 36 mo (range, 15-66 mo). When MRI was used as the gold standard, our false-positive rate was zero. Conclusion: By including the entire head during follow-up 18F-FDG PET/CT scans of patients with non-small cell lung cancer, brain metastases can be detected earlier while still asymptomatic. But, given the additional scan time, radiation, and low incidence of new brain metastases in asymptomatic patients, the cost-to-benefit ratio should be weighed by each institution.

AB - The brain is the most common site of distant metastasis from lung cancer. Thus, MRI of the brain at initial staging is routinely performed, but if this examination is negative a follow-up examination is often not performed. This study evaluates the incidence of asymptomatic brain metastases in non-small cell lung cancer patients detected on follow-up 18F-FDG PET/CT scans. Methods: In this Institutional Review Board-approved retrospective review, all vertex to thigh 18F-FDG PET/CT scans in patients with all subtypes of lung cancer from August 2014 to August 2016 were reviewed. A total of 1,175 18F-FDG PET/CT examinations in 363 patients were reviewed. Exclusion criteria included brain metastases on initial staging, histologic subtype of small-cell lung cancer, and no follow-up 18F-FDG PET/CT examinations. After our exclusion criteria were applied, a total of 809 follow-up 18F-FDG PET/CT scans in 227 patients were included in the final analysis. The original report of each 18F-FDG PET/CT study was reviewed for the finding of brain metastasis. The finding of a new brain metastasis prompted a brain MRI, which was reviewed to determine the accuracy of the 18F-FDG PET/CT. Results: Five of 227 patients with 809 follow-up 18F-FDG PET/CT scans reviewed were found to have incidental brain metastases. The mean age of the patients with incidental brain metastasis was 68 y (range, 60-77 y). The mean time from initial diagnosis to time of detection of incidental brain metastasis was 36 mo (range, 15-66 mo). When MRI was used as the gold standard, our false-positive rate was zero. Conclusion: By including the entire head during follow-up 18F-FDG PET/CT scans of patients with non-small cell lung cancer, brain metastases can be detected earlier while still asymptomatic. But, given the additional scan time, radiation, and low incidence of new brain metastases in asymptomatic patients, the cost-to-benefit ratio should be weighed by each institution.

KW - Brain MRI

KW - Brain metastasis

KW - F-FDG PET/CT

KW - Incidental

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85028864344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028864344&partnerID=8YFLogxK

U2 - 10.2967/jnmt.117.194571

DO - 10.2967/jnmt.117.194571

M3 - Article

C2 - 28705927

AN - SCOPUS:85028864344

VL - 45

SP - 193

EP - 197

JO - Journal of Nuclear Medicine Technology

JF - Journal of Nuclear Medicine Technology

SN - 0091-4916

IS - 3

ER -